On Friday, 17th March 2017, xRapid-Group and the French National Reference Centre for Malaria (CNRP and AP-HP) formalised a long run partnership. The two parties were represented by Jean Viry-Babel, xRapid’s CEO, and Marc Thellier, parasitologist and laboratory manager at the CNRP.
The agreement signature took place in the very luxurious Luxembourg Palace in Paris in the presence of Senator Olivier Cadic, representative of French people abroad.
“We could only be seduced by xRapid dynamism and their very innovative product: an automated diagnostic tool which avoids uncertainties that exist in traditional methods and doesn’t require any experience”, said Marc Thellier.
And thanks to this obvious interest, “a public-private partnership is now running, in spite of the administrative burden” added Jean Viry-Babel.
Partnership agreement content
Even though the partnership was formalised last week, xRapid has been working with the CNRP at the Pitié-Salpêtrière Hospital in Paris for more than a year. They helped us test and approve xRapid-Malaria and xRapid-Lab and implement our slide staining protocol.
The main novelty of this private-public partnership is that xRapid is now supporting the PhD student, Ilhame Tantaoui. She is conducting a comparative study between xRapid diagnostic apps and the traditional microscopic analysis. Now that the agreement is concretised, xRapid and the CNRP are looking forward to joining their forces to eradicate malaria through accurate and efficient diagnosis.